Ean-Jeong Seo

Ean-Jeong Seo

Auto-generated profile, based on publicly available information

Ean-Jeong Seo

Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MSMohamed E. M. Saeed
Mohamed E. M. Saeed
RYRumeysa Yucer
Rumeysa Yucer
MMMona Dawood Ahmed Mohammed
Mona Dawood Ahmed Mohammed
MHMohamed-Elamir F. Hegazy
Mohamed-Elamir F. Hegazy
ADAssia Drif
Assia Drif
Thomas EfferthThomas Efferth
Thomas Efferth
The improvement of cancer chemotherapy remains a major challenge, and thus new drugs are urgently required to develop new treatment regimes. Curcumin, a polyphenolic antioxidant derived from the rhizome of turmeric (Curcuma longa L.), has undergone extensive preclinical investigations and, thereby, displayed remarkable efficacy in vitro and in vivo against cancer and other disorders. However, pharmacological limitations of curcumin stimulated the synthesis of numerous novel curcumin analogs, which need to be evaluated for their therapeutic potential. In the present study, we calculated the binding affinities of 50 curcumin derivatives to known cancer-related target proteins of curcumin, i.e., epidermal growth factor receptor (EGFR) and nuclear factor κB (NF-κB) by using a molecular docking approach. The binding energies for EGFR were in a range of −12.12 (±0.21) to −7.34 (±0.07) kcal/mol and those for NF-κB ranged from −12.97 (±0.47) to −6.24 (±0.06) kcal/mol, indicating similar binding affinities of the curcumin compounds for both target proteins. The predicted receptor-ligand binding constants for EGFR and curcumin derivatives were in a range of 0.00013 (±0.00006) to 3.45 (±0.10) µM and for NF-κB in a range of 0.0004 (±0.0003) to 10.05 (±4.03) µM, indicating that the receptor-ligand binding was more stable for EGFR than for NF-κB. Twenty out of 50 curcumin compounds showed binding energies to NF-κB smaller than −10 kcal/mol, while curcumin as a lead compound revealed free binding energies of >−10 kcal/mol. Comparable data were obtained for EGFR: 15 out of 50 curcumin compounds were bound to EGFR with free binding energies of <−10 kcal/mol, while the binding affinity of curcumin itself was >−10 kcal/mol. This indicates that the derivatization of curcumin may indeed be a promising strategy to improve targe specificity and to obtain more effective anticancer drug candidates. The in silico results have been exemplarily validated using microscale thermophoresis. The bioactivity has been further investigated by using resazurin cell viability assay, lactate dehydrogenase assay, flow cytometric measurement of reactive oxygen species, and annexin V/propidium iodide assay. In conclusion, molecular docking represents a valuable approach to facilitate and speed up the identification of novel targeted curcumin-based drugs to treat cancer.

10 June 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
JKJohannes Krieger
Johannes Krieger
TSToni Smeilus
Toni Smeilus
MKMarcel Kaiser
Marcel Kaiser
ESEan‐Jeong Seo
Ean‐Jeong Seo
Thomas EfferthThomas Efferth
Thomas Efferth
AGAthanassios Giannis
Athanassios Giannis

15 April 2016 in Molecules
Verified
Journal Article
Open access
PDF file
ESEan-Jeong Seo
Ean-Jeong Seo
SMSaeed E M Mohamed
Saeed E M Mohamed
BLBetty Yuen Kwan Law
Betty Yuen Kwan Law
WAWu An-Guo
Wu An-Guo
Onat KadiogluOnat Kadioglu
Onat Kadioglu
Thomas EfferthThomas Efferth
Thomas Efferth
Drug resistance and the severe side effects of chemotherapy necessitate the development of novel anticancer drugs. Natural products are a valuable source for drug development. Scopoletin is a coumarin compound, which can be found in several Artemisia species and other plant genera. Microarray-based RNA expression profiling of the NCI cell line panel showed that cellular response of scopoletin did not correlate to the expression of ATP-binding cassette (ABC) transporters as classical drug resistance mechanisms (ABCB1, ABCB5, ABCC1, ABCG2). This was also true for the expression of the oncogene EGFR and the mutational status of the tumor suppressor gene, TP53. However, mutations in the RAS oncogenes and the slow proliferative activity in terms of cell doubling times significantly correlated with scopoletin resistance. COMPARE and hierarchical cluster analyses of transcriptome-wide mRNA expression resulted in a set of 40 genes, which all harbored binding motifs in their promoter sequences for the transcription factor, NF-κB, which is known to be associated with drug resistance. RAS mutations, slow proliferative activity, and NF-κB may hamper its effectiveness. By in silico molecular docking studies, we found that scopoletin bound to NF-κB and its regulator IκB. Scopoletin activated NF-κB in a SEAP-driven NF-κB reporter cell line, indicating that NF-κB might be a resistance factor for scopoletin. In conclusion, scopoletin might serve as lead compound for drug development because of its favorable activity against tumor cells with ABC-transporter expression, although NF-κB activation may be considered as resistance factor for this compound. Further investigations are warranted to explore the full therapeutic potential of this natural product.

21 March 2019 in Natural Product Research
Verified
Journal Article
Closed access
LKLeonidah Kerubo
Leonidah Kerubo
GMGacheru Martin Mbogo
Gacheru Martin Mbogo
EKEric Korir
Eric Korir
RORuth Omole
Ruth Omole
ESEan-Jeong Seo
Ean-Jeong Seo
Thomas EfferthThomas Efferth
Thomas Efferth
In our continuous search for cytotoxic compounds from the genus Zanthoxylum, chromatographic separation of the MeOH/CH2Cl2 (1:1) extract of Z. chalybeum yielded one new alkamide; 4-(isoprenyloxy)-3-methoxy-3,4-deoxymethylenedioxyfagaramide (1) and a known one; fagaramide (2). Similarly, from the MeOH/CH2Cl2 (1:1) extract of the stem bark of Z. parachanthum four known compounds; canthin-6-one (3), dihydrochelerythrine (4), lupeol (5) and sesamin (6) were isolated. Characterization of the structures of these compounds was achieved using spectroscopic techniques (NMR and MS). Using resazurin reduction assay 1, 3 and 6 displayed moderate cytotoxicity with IC50 values below 50 μM against the drug sensitive CCRF-CEM and multidrug-resistant CEM/ADR5000 leukemia cell lines. It is interesting to note that 3 was more active than the standard drug, doxorubicin against CEM/ADR5000 leukemia cells. Compounds 3 and 6 showed good selectivity on leukemia cells than normal cells. In future studies 3 should be tested against a panel of drug resistant human cells.

1 November 2017 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
VCVanessa Colligs
Vanessa Colligs
SHSteven Peter Hansen
Steven Peter Hansen
DIDennis Imbri
Dennis Imbri
ESEan-Jeong Seo
Ean-Jeong Seo
Onat KadiogluOnat Kadioglu
Onat Kadioglu
TOTill Opatz
Till Opatz

3 March 2017 in Marine Drugs
Verified
Journal Article
Open access
PDF file
TSTanja Schirmeister
Tanja Schirmeister
SOSwarna Oli
Swarna Oli
HWHongmei Wu
Hongmei Wu
GSGerardo Della Sala
Gerardo Della Sala
Valeria CostantinoValeria Costantino
Valeria Costantino
Thomas EfferthThomas Efferth
Thomas Efferth
The 6-epimer of the plakortide H acid (1), along with the endoperoxides plakortide E (2), plakortin (3), and dihydroplakortin (4) have been isolated from a sample of the Caribbean sponge Plakortis halichondrioides. To perform a comparative study on the cytotoxicity towards the drug-sensitive leukemia CCRF-CEM cell line and its multi-drug resistant subline CEM/ADR5000, the acid of plakortin, namely plakortic acid (5), as well as the esters plakortide E methyl ester (6) and 6-epi-plakortide H (7) were synthesized by hydrolysis and Steglich esterification, respectively. The data obtained showed that the acids (1, 2, 5) exhibited potent cytotoxicity towards both cell lines, whereas the esters showed no activity (6, 7) or weaker activity (3, 4) compared to their corresponding acids. Plakortic acid (5) was the most promising derivative with half maximal inhibitory concentration (IC50) values of ca. 0.20 µM for both cell lines.